Wir sind mit live! Mehr erfahren
SCTL

Societal CDMO, Inc. Common Stock
SCTL

Nicht mehr börsennotiert

SCTL wurde am 5. April 2024 von der Börse genommen.

Zurück zu den Rankings
 

Profil: Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. They have an expertise in solving complex manufacturing problems, the Company provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.

Mitarbeiter: 258

Gesundheitswesen Arzneimittelhersteller – allgemein

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 0 %
Neutral 0 %
Negativ 0 %
Neutral
Business Wire
vor 2 Jahren
SOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTL
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Societal CDMO, Inc. (NasdaqCM: SCTL) to CoreRx, Inc. Under the terms of the proposed transaction, shareholders of Societal will receive $1.10 in cash for each share of Societal that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the cons.
SOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTL
Neutral
Business Wire
vor 2 Jahren
SOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTL
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Societal CDMO, Inc. (NasdaqCM: SCTL) to CoreRx, Inc. Under the terms of the proposed transaction, shareholders of Societal will receive $1.10 in cash for each share of Societal that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the cons.
SOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTL
Positiv
InvestorPlace
vor 2 Jahren
Why Is Societal CDMO (SCTL) Stock Up 133% Today?
Societal CDMO (NASDAQ: SCTL ) stock is rocketing higher on Thursday after the pharmaceutical development and manufacturing company announced an acquisition agreement with CoreRx. This agreement will have CoreRx acquiring Societal CDMO with a tender offer for SCTL shares.
Why Is Societal CDMO (SCTL) Stock Up 133% Today?
Neutral
Business Wire
vor 2 Jahren
SCTL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Societal CDMO, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Societal CDMO, Inc. (NASDAQ: SCTL) to CoreRx, Inc. for $1.10 per share in cash is fair to Societal CDMO shareholders. Halper Sadeh encourages Societal CDMO shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Societ.
SCTL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Societal CDMO, Inc. Is Fair to Shareholders
Neutral
GlobeNewsWire
vor 2 Jahren
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
Neutral
GlobeNewsWire
vor 2 Jahren
Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets
Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
Neutral
GlobeNewsWire
vor 2 Jahren
Societal CDMO Reports Inducement Grants for New Staff
SAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced the addition of new employees to fill open roles throughout the organization.
Societal CDMO Reports Inducement Grants for New Staff
Nachrichtenrankings ansehen
Kursdiagramme mit Lightweight Charts™ umgesetzt